Fasting insulin levels in patients with NAFLD and NASH were, however, significantly higher compared to controls (27.8±2.3 and 43.9±4.1 [all patients 38.9±3.1] vs. 14.9±0.9 mU/l, p<0.0001). This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.